Sudduth, Christopher L.
Smits, Patrick J.
Vivero, Matthew P.
Cheng, Yu Sheng
Ad, Michal
Konczyk, Dennis J.
Bischoff, Joyce
Warman, Matthew L.
Greene, Arin K.
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD093735)
Article History
Received: 20 December 2022
Accepted: 16 May 2023
First Online: 8 July 2023
Competing interests
: Patent to treat AVM with MEK inhibitors (AKG, MLW). The remaining authors have no competing interests.